Literature DB >> 2704248

Novel and versatile superfusion system. Its use in the evaluation of some spasmogenic and spasmolytic agents using guinea-pig isolated tracheal smooth muscle.

R A Coleman1, A T Nials.   

Abstract

We have developed a novel, eight-chamber superfusion system that is suitable for a variety of applications involving the study of both contraction and relaxation of smooth muscle preparations, and the effect of agents that interfere with these actions. The system allows electrical stimulation of preparations, and thus neuronally mediated responses and agents that interfere with neurotransmission may also be studied. To demonstrate some of the applications of the system, we have evaluated both spasmogenic and spasmolytic agents on the guinea-pig isolated tracheal strip preparation. The potency and the times for onset and offset of action of the spasmogens, acetylcholine, histamine, and prostaglandin F2 alpha, and the spasmolytics, isoprenaline, clenbuterol, salbutamol, papaverine, N-ethylcarboxamide adenosine, theophylline, and verapamil, have been investigated. The spasmolytic agents have been tested against both prostaglandin F2 alpha-induced tone and electrically induced contractile responses of the guinea-pig trachea. This superfusion system has several advantages over previously described superfusion or immersion techniques. It is compact and allows simultaneous study of up to eight preparations. It is suitable for a wide range of tissues, and the use of this system avoids the necessity of repeatedly washing drugs from organ baths. However, one of the most important applications of the system is its use in the study of rates of onset and offset of drug action. We believe, therefore, that this system represents an important alternative to the classical organ bath for in vitro pharmacological experimentation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2704248     DOI: 10.1016/0160-5402(89)90023-5

Source DB:  PubMed          Journal:  J Pharmacol Methods        ISSN: 0160-5402


  10 in total

1.  Functional evidence for NO-synthase activation by substance P through a mechanism not involving classical tachykinin receptors in guinea-pig ileum in vitro.

Authors:  R Garcia-Villar; C Dupuis; J P Martinolle; J Fioramonti; L Buéno
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

2.  Antihistamine Effect of a Pure Bioactive Compound Isolated from Slug (Diplosolenodes occidentalis) Material.

Authors:  A S Jacob; O R Simon; D Wheatle; P Ruddock; K McCook
Journal:  West Indian Med J       Date:  2014-07-03       Impact factor: 0.171

3.  Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.

Authors:  D I Ball; R T Brittain; R A Coleman; L H Denyer; D Jack; M Johnson; L H Lunts; A T Nials; K E Sheldrick; I F Skidmore
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

4.  The pharmacology of fluparoxan: a selective alpha 2-adrenoceptor antagonist.

Authors:  C A Halliday; B J Jones; M Skingle; D M Walsh; H Wise; M B Tyers
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

5.  Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H(1) and H(3) receptors.

Authors:  R J Slack; L J Russell; D A Hall; M A Luttmann; A J Ford; K A Saunders; S T Hodgson; H E Connor; C Browning; K L Clark
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

6.  Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol.

Authors:  A T Nials; M J Sumner; M Johnson; R A Coleman
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

7.  Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.

Authors:  M J Robertson; J C Barnes; G M Drew; K L Clark; F H Marshall; A Michel; D Middlemiss; B C Ross; D Scopes; M D Dowle
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

8.  Effect of salmeterol on human nasal epithelial cell ciliary beating: inhibition of the ciliotoxin, pyocyanin.

Authors:  K Kanthakumar; D R Cundell; M Johnson; P J Wills; G W Taylor; P J Cole; R Wilson
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

9.  Effects of beta-adrenoceptor agonists in human bronchial smooth muscle.

Authors:  A T Nials; R A Coleman; M Johnson; H Magnussen; K F Rabe; C J Vardey
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

10.  Functional in vitro tension measurements of fascial tissue - a novel modified superfusion approach.

Authors:  R Schleip; W Klingler; S Wearing; I Naylor; M Zuegel; K Hoppe
Journal:  J Musculoskelet Neuronal Interact       Date:  2016-09-07       Impact factor: 2.041

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.